Aclarion Expands AI Tool To Help Doctors Pinpoint Back Pain, Eyes Growth As More Hospitals Adopt Nociscan Technology

Aclarion, Inc. (NASDAQ: ACON) is expanding its Nociscan platform, which utilizes AI to assist doctors in diagnosing chronic low back pain. The company is focused on increasing adoption of this technology through ongoing clinical trials, enhanced engagement with physicians, and reimbursement initiatives in the UK and US. CEO Brent Ness emphasized the company's commitment to disciplined execution and building a scalable technology platform, aiming to create long-term value for both patients and shareholders.